Cholestatic Jaundice as a Result of Combination Designer Supplement Ingestion

OBJECTIVE To report a case of cholestatic jaundice as a result of combination herbal and designer supplement use. CASE SUMMARY A 50-year-old Hispanic male presented to the hospital with a 1-week history of significant painless jaundice; total bilirubin on admission was 29.4 mg/dL. He reported use of both herbal (creatine and whey protein) and designer (Incredible Bulk and Spartan 45) supplements concurrently for approximately 2 months. Upon admission, all supplements were discontinued and multiple laboratory and diagnostic tests were ordered. On day 6 of his hospital admission, a liver biopsy was performed, the results of which indicated drug-induced hepatotoxicity. On day 9 he was discharged with prescriptions for ursodeoxycholic acid and hydroxyzine. Three months post hospital discharge, the patient continued to be supplement-free and bilirubin had decreased substantially. DISCUSSION Anabolic-androgenic steroids are capable of causing hepatotoxicity, and multiple cases reported in the literature support this. A case report described hepatotoxicity secondary to both creatine and whey protein consumption, and several reports have described liver damage secondary to designer supplement use. To our knowledge, this is the first case to describe hepatotoxicity as a result of combination herbal and designer supplement use. The Roussel Uclaf Causality Assessment Method (RUCAM) score for drug-induced hepatotoxicity indicated a highly probable correlation between the use of combination supplements and cholestatic jaundice. CONCLUSIONS Health care professionals need to be aware of complications associated with designer supplement use and should be able to identify patients who would benefit from education on herbal and designer supplement use.

[1]  M. McDowell,et al.  Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). , 2011, NCHS data brief.

[2]  K. Deniz,et al.  Cholestatic liver injury associated with whey protein and creatine supplements. , 2008, Seminars in liver disease.

[3]  F. Gordon,et al.  Methasteron-associated cholestatic liver injury: clinicopathologic findings in 5 cases. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  A. Duarte-Rojo,et al.  Anabolic–androgenic steroids and liver injury , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[5]  S. Verma,et al.  Hepatotoxicity associated with dietary supplements containing anabolic steroids. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  A. Nadir,et al.  Cholestatic Jaundice and IgA Nephropathy Induced by OTC Muscle Building Agent Superdrol , 2006, The American Journal of Gastroenterology.

[7]  J. Senior,et al.  Drug-related hepatotoxicity. , 2006, The New England journal of medicine.

[8]  N. Kaplowitz,et al.  Drug Hepatotoxicity , 1990 .

[9]  R. C. Hall,et al.  Abuse of Supraphysiologic Doses of Anabolic Steroids , 2005, Southern medical journal.

[10]  D. S̆timac,et al.  Androgenic/Anabolic steroid-induced toxic hepatitis. , 2002, Journal of clinical gastroenterology.

[11]  A. Flahault,et al.  Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. , 1993, Journal of clinical epidemiology.

[12]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.